
GC33266
JNJ-38877618
Also known as 6-[difluoro-(6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline
JNJ-38877618 is a potent, highly selective, orally bioavailable Met kinase inhibitor with IC50s of 2 and 3 nM for wild type and mutant Met, respectively
ChemicalCAS943540-74-7MW374.35FormulaC20H12F2N6
- CAS number
- 943540-74-7
- Molecular weight
- 374.35
- Formula
- C20H12F2N6
- Solubility
- DMSO : 5 mg/mL (13·36 mM)
- InChIKey
- KOAWAWHSMVKCON-UHFFFAOYSA-N
- Catalogue number
- GC33266
- Brand
- GLPBIO
Computed properties PubChem CID 57654476 · XLogP 2.7 · TPSA 68.9 Ų · H-bond donors 0
- XLogP
- 2.7
- TPSA
- 68.9 Ų
- H-bond donors
- 0
- H-bond acceptors
- 7
- Rotatable bonds
- 3
- Heavy atoms
- 28
SMILES C1=CC2=C(C=CC(=C2)C(C3=NN=C4N3N=C(C=C4)C5=CC=NC=C5)(F)F)N=C1
Computed descriptors from PubChem (CID 57654476), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il